Free equity investment tool of Japanese companies

Financial Indicator Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

KAWAKAMI PAINT MFG.

KYOWA LEATHER CLOTH

Tokuyama

TAKAGI SEIKO

エステー

Shiseido

TEIJIN　

ASAHIPEN

katakura chikkarin

HOKKO CHEMICAL INDUSTRY

TAIYO NIPPON SANSO

TODA KOGYO

W-SCOPE

JAPAN U-PICA

CEMEDINE

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

10/30 Real Estate (DAIBIRU:BBB→A e..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

Hitachi Zosen etc.

NIPPON COKE & ENGINEERING

メルコホールディングス

ROHM

日本セラミック etc.

Financial Indicator Details: CEMEDINE (Annual )

Two or more periods are displayed by each of financial indicator collectively.Two or more companies can be compared and financial indicator data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Indicator data

Indicator Summary: CEMEDINE (Annual )

Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	-1.56% (-12.05%)	1.14% (-0.50%)	2.38% (1.53%)	2.74% (-1.67%)	1.10% (3.05%)
C/F margin (Industry Average)	0.21% (-3.31%)	2.51% (8.51%)	6.53% (7.04%)	3.56% (6.35%)	4.29% (8.25%)
ROA (Industry Average)	-1.83% (0.52%)	1.30% (1.04%)	2.82% (2.07%)	3.24% (0.06%)	1.41% (2.71%)
ROE (Industry Average)	-3.89% (-1.43%)	2.64% (0.03%)	5.64% (2.96%)	6.50% (4.68%)	2.81% (4.57%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	2.70% (5.01%)	3.58% (2.61%)	5.17% (-0.40%)	3.42% (8.16%)
Sales growth (Industry Average)	- (-)	-4.61% (-2.67%)	6.01% (5.36%)	5.18% (1.07%)	10.80% (2.24%)
Net profit growth (Industry Average)	- (-)	169.62% (203.46%)	121.11% (63.25%)	21.23% (3.89%)	-55.27% (90.38%)
Operating C/F growth (Industry Average)	- (-)	1,035.73% (275.10%)	176.02% (35.09%)	-42.67% (-6.09%)	33.55% (138.39%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	47.14% (53.80%)	49.44% (54.51%)	49.98% (55.00%)	49.90% (53.59%)	50.14% (56.30%)
Liquidity ratio (Industry Average)	167.78% (217.72%)	174.23% (225.70%)	169.07% (237.55%)	164.25% (239.89%)	164.68% (236.21%)
C/F ratio current liabilities (Industry Average)	15,860.61% (777.21%)	1,368.66% (303.31%)	0.55% (434.79%)	1.05% (929.73%)	811.58% (573.30%)
Quick ratio (Industry Average)	134.52% (138.97%)	141.54% (148.85%)	135.30% (156.17%)	130.45% (160.84%)	129.80% (156.81%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	99.38day (83.89day)	112.24day (94.27day)	0.10day (93.96day)	0.11day (97.92day)	99.13day (98.27day)
Inventory turnover (Industry Average)	34.36day (54.45day)	34.85day (52.58day)	0.03day (52.64day)	0.03day (56.59day)	30.50day (58.68day)
Payable turnover (Industry Average)	90.20day (45.01day)	96.75day (49.82day)	0.10day (49.52day)	0.11day (52.10day)	94.19day (51.12day)
Working capita turnover (Industry Average)	43.54day (93.32day)	50.34day (97.02day)	0.03day (97.08day)	0.03day (102.41day)	35.45day (105.83day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	11.35% (34.57%)	12.33% (1.49%)	1.10% (-3.85%)	5.98% (21.16%)
Dividend Yield (Industry Average)	4.57% (3.20%)	1.80% (1.93%)	- (2.17%)	- (2.45%)	2.29% (2.07%)
PER (Industry Average)	-14.00% (25.22%)	22.40% (23.06%)	11.38% (16.22%)	9.49% (29.19%)	22.49% (16.58%)
PBR (Industry Average)	0.54% (0.86%)	0.59% (1.06%)	0.64% (1.04%)	0.61% (0.95%)	0.63% (1.08%)
PCFR (Industry Average)	103.93% (7.18%)	10.19% (9.23%)	4.14% (-2.43%)	7.31% (9.50%)	5.80% (7.56%)
PSR (Industry Average)	0.21% (0.77%)	0.25% (0.88%)	0.27% (1.10%)	0.26% (0.90%)	0.24% (1.01%)

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Profitability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Net profit margin (Industry Average)	-1.11% (-27.66%)	1.45% (-4.34%)	2.17% (-5.37%)	1.49% (-10.69%)	0.52% (8.92%)
C/F margin (Industry Average)	- (0.87%)	- (1.04%)	- (0.82%)	- (-0.81%)	- (-39.63%)
ROA (Industry Average)	-1.35% (0.52%)	1.71% (0.92%)	2.54% (1.42%)	1.79% (-0.27%)	0.61% (1.53%)
ROE (Industry Average)	-2.82% (-0.84%)	3.41% (-0.46%)	5.21% (1.81%)	3.59% (3.42%)	1.24% (2.62%)
Growth	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Equity growth (Industry Average)	- (-)	3.25% (3.64%)	2.89% (3.03%)	2.33% (0.04%)	0.87% (3.91%)
Sales growth (Industry Average)	- (-)	-4.65% (-3.48%)	5.45% (6.70%)	2.83% (0.75%)	-0.17% (-1.74%)
Net profit growth (Industry Average)	- (-)	224.73% (166.48%)	57.04% (43.48%)	-29.46% (-47.04%)	-65.13% (62.14%)
Operating C/F growth (Industry Average)	- (-)	- (89.80%)	- (77.44%)	- (-44.41%)	- (46.89%)
Stability	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Capital adequacy (Industry Average)	47.92% (56.79%)	50.04% (57.65%)	48.82% (57.17%)	49.88% (55.93%)	49.57% (57.57%)
Liquidity ratio (Industry Average)	158.78% (337.22%)	161.06% (276.75%)	160.70% (266.94%)	156.70% (314.47%)	- (233.84%)
C/F ratio current liabilities (Industry Average)	- (48.90%)	- (53.10%)	- (31.35%)	- (76.77%)	- (31.87%)
Quick ratio (Industry Average)	121.77% (167.28%)	123.49% (183.78%)	120.69% (174.83%)	114.88% (228.06%)	- (169.77%)
Turnover	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Receivables turnover (Industry Average)	99.56day (87.55day)	112.32day (98.39day)	0.11day (95.88day)	0.10day (98.58day)	- (67.18day)
Inventory turnover (Industry Average)	32.71day (50.17day)	33.54day (48.43day)	0.03day (47.43day)	0.03day (50.67day)	- (38.21day)
Payable turnover (Industry Average)	95.40day (45.70day)	102.94day (51.63day)	0.11day (51.13day)	0.11day (53.57day)	- (34.24day)
Working capita turnover (Industry Average)	36.87day (92.02day)	42.91day (95.19day)	0.02day (92.19day)	0.02day (95.69day)	- (71.15day)
Stock etc.	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Market Value growth (Industry Average)	- (-)	11.35% (34.46%)	12.33% (3.11%)	1.10% (-3.30%)	5.98% (24.19%)
Dividend Yield (Industry Average)	- (0.15%)	- (0.09%)	- (0.10%)	- (0.16%)	- (0.15%)
PER (Industry Average)	-20.05% (34.12%)	17.90% (27.80%)	12.80% (13.58%)	18.35% (22.26%)	55.80% (26.42%)
PBR (Industry Average)	0.56% (0.97%)	0.61% (1.21%)	0.66% (1.17%)	0.66% (1.08%)	0.69% (1.54%)
PCFR (Industry Average)	- (0.27%)	- (0.62%)	- (0.23%)	- (0.08%)	- (4.97%)
PSR (Industry Average)	0.22% (3.42%)	0.26% (4.34%)	0.27% (3.67%)	0.27% (4.37%)	0.29% (10.14%)

Financial Indicator Details: CEMEDINE

Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	-1.56%	1.14%	2.38%	2.74%	1.10%
C/F margin	0.21%	2.51%	6.53%	3.56%	4.29%
ROA	-1.83%	1.30%	2.82%	3.24%	1.41%
ROE	-3.89%	2.64%	5.64%	6.50%	2.81%
Recurring margin	-0.75%	2.66%	4.70%	3.39%	4.24%
EBIT margin	-2.28%	2.52%	-	-	1.97%
EBITDA margin	0.11%	5.14%	-	-	3.86%
NOPAT margin	-1.37%	1.51%	-	-	1.18%
Sales SG rates	77.56%	74.25%	99.97%	99.97%	73.29%
Sales SG&A rates	23.20%	23.00%	0.02%	0.02%	22.72%
Sales R&D expenses rates	-	-	-	-	-
Sales depreciation rates	2.40%	2.61%	-	-	1.89%
Capital expenditures net sales ratio	-0.59%	-1.84%	-	-	-2.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-3.94%	-99.88%	-3.17%	112,144.45%
Equity growth	-	2.70%	3.58%	5.17%	3.42%
Total assets growth	-	-2.08%	2.47%	5.35%	2.92%
Sales growth	-	-4.61%	6.01%	5.18%	10.80%
Net profit growth	-	169.62%	121.11%	21.23%	-55.27%
Operating C/F growth	-	1,035.73%	176.02%	-42.67%	33.55%
Recurring profit growth	-	434.47%	87.53%	-24.19%	38.51%
EBIT growth	-	205.50%	-99.83%	18.12%	49,181.52%
EBITDA growth	-	4,099.00%	-99.87%	11.45%	66,167.98%
NOPAT growth	-	205.50%	-99.83%	18.12%	49,181.56%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	47.14%	49.44%	49.98%	49.90%	50.14%
Liquidity ratio	167.78%	174.23%	169.07%	164.25%	164.68%
C/F ratio current liabilities	15,860.61%	1,368.66%	0.55%	1.05%	811.58%
Quick ratio	134.52%	141.54%	135.30%	130.45%	129.80%
Fixed ratio	47.78%	41.92%	0.03%	0.03%	36.63%
D/E ratio	13.36%	11.35%	-	-	5.45%
Loan to Value Ratio	6.30%	5.61%	-	-	2.73%
Business investment C/F ratio	-283.10%	-73.56%	-0.01%	-0.03%	-46.59%
Liabilities with interest growth	-	-12.77%	-99.94%	-	99,900.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	64.84day	65.29day	0.07day	0.06day	65.97day
Receivables turnover	99.38day	112.24day	0.10day	0.11day	99.13day
Inventory turnover	34.36day	34.85day	0.03day	0.03day	30.50day
Fixed assets turnover	69.98day	66.11day	0.05day	0.05day	52.68day
Total asset turnover	310.67day	318.91day	308.24day	308.73day	286.78day
Payable turnover	90.20day	96.75day	0.10day	0.11day	94.19day
Capital turnover	55.29day	57.97day	0.05day	0.05day	46.91day
Equity turnover	146.46day	157.69day	154.07day	154.07day	143.81day
Working capita turnover	43.54day	50.34day	0.03day	0.03day	35.45day
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 3 B	¥ 3 B	¥ 3 M	¥ 3 M	¥ 4 B
Accounts receivable-trade	¥ 5 B	¥ 5 B	¥ 6 M	¥ 6 M	¥ 6 B
Other Current Assets	¥ 7 B	¥ 8 B	¥ 8 M	¥ 9 M	¥ 9 B
Current Assets	¥ 11 B	¥ 11 B	¥ 12 M	¥ 13 M	¥ 13 B
Tangible Assets	¥ 3 B	¥ 3 B	¥ 3 M	¥ 3 M	¥ 3 B
Intangible Assets	¥ 236 M	¥ 248 M	¥ 210 K	¥ 637 K	¥ 544 M
Investment etc.	¥ 1 B	¥ 1 B	¥ 17 B	¥ 18 B	¥ 1 B
Total Assets	¥ 17 B	¥ 16 B	¥ 17 B	¥ 18 B	¥ 18 B
Current Liabilities	¥ 6 B	¥ 6 B	¥ 7 M	¥ 8 M	¥ 8 B
Fixed Liabilities	¥ 2 B	¥ 1 B	¥ 1 M	¥ 1 M	¥ 1 B
Liabilities with interest	¥ 1 B	¥ 942 M	¥ 510 K	¥ 510 K	¥ 510 M
Net Assets	¥ 8 B	¥ 8 B	¥ 8 B	¥ 9 B	¥ 9 B
Capital stock	¥ 3 B	¥ 3 B	¥ 3 M	¥ 3 M	¥ 3 B
Capital surplus etc.	¥ 5 B	¥ 5 B	¥ 8 B	¥ 9 B	¥ 6 B
Liabilities and net assets	¥ 17 B	¥ 16 B	¥ 17 M	¥ 18 M	¥ 18 B
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 20 B	¥ 19 B	¥ 20 B	¥ 21 B	¥ 23 B
Cost of Sales	¥ 15 B	¥ 14 B	¥ 20 B	¥ 21 B	¥ 17 B
Gross profit	¥ 4 B	¥ 4 B	¥ 5 M	¥ 5 M	¥ 6 B
Other income	¥ 319 M	¥ 104 M	¥ 155 K	¥ 360 K	¥ 177 M
SG&A	¥ 4 B	¥ 4 B	¥ 4 M	¥ 4 M	¥ 5 B
Other expenses	¥ 459 M	¥ 392 M	¥ 537 K	¥ 479 K	¥ 834 M
Net income	¥ -315 M	¥ 219 M	¥ 485 M	¥ 588 M	¥ 263 M
Operating income	¥ -155 M	¥ 525 M	¥ 899 M	¥ 726 M	¥ 945 M
Ordinary Income	¥ -152 M	¥ 511 M	¥ 959 M	¥ 727 M	¥ 1 B
EBITDA	¥ 23 M	¥ 988 M	¥ 1 M	¥ 1 M	¥ 917 M
Income before income taxes	¥ -463 M	¥ 469 M	¥ 797 K	¥ 945 K	¥ 462 M
Depreciation	¥ 483 M	¥ 502 M	¥ 439 K	¥ 435 K	¥ 449 M
R&D expenses	-	-	-	-	-
Income taxes	¥ -167 M	¥ 231 M	¥ 279 K	¥ 337 K	¥ 174 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	¥ 42 M	¥ 482 M	¥ 1 B	¥ 763 M	¥ 1 B
Investment CF	¥ -6 M	¥ -382 M	¥ -286 K	¥ -721 K	¥ -392 M
Financial CF	¥ -207 M	¥ -227 M	¥ -625 K	¥ -143 K	¥ -136 M
Foreign Exchange Effects	¥ -6 M	¥ 2 M	¥ -896	¥ -1 K	¥ 25 M
Net Change in Cash	¥ -177 M	¥ -125 M	¥ 420 K	¥ -102 K	¥ 515 M
Free CF	¥ 35 M	¥ 99 M	¥ 1 B	¥ 762 M	¥ 627 M
Capital expenditures	¥ -120 M	¥ -354 M	¥ -187 K	¥ -284 K	¥ -474 M
Cash dividends paid	¥ -202 M	¥ -88 M	¥ -116 K	¥ -143 K	¥ -135 M
Repayment loans	¥ -600 M	¥ -648 M	¥ -942 K	¥ -510 K	¥ -510 M
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -178 M	¥ -74 M	¥ -103 K	¥ -117 K	¥ -116 M
Net income	¥ -315 M	¥ 219 M	¥ 485 K	¥ 588 K	¥ 263 M
Purchase of treasury stock	¥ -5 M	¥ -376 K	¥ -77 K	¥ -377	¥ 10 M
Other Change in Stockholders Equity	¥ -52 M	¥ -1 K	¥ -2	¥ -1	-
Other Change in Net Assets	¥ -275 M	¥ 73 M	¥ -7 K	¥ -26 K	¥ 152 M
Net Change in Net Assets	¥ -827 M	¥ 218 M	¥ 298 K	¥ 445 K	¥ 309 M

Financial Indicator Details: CEMEDINE

Non-Consolidated :Indicator Consolidated | Non-Consolidated

Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Profitability
Net profit margin	-1.11%	1.45%	2.17%	1.49%	0.52%
C/F margin	-	-	-	-	-
ROA	-1.35%	1.71%	2.54%	1.79%	0.61%
ROE	-2.82%	3.41%	5.21%	3.59%	1.24%
Recurring margin	-0.06%	3.01%	4.19%	2.71%	2.93%
EBIT margin	-1.78%	2.80%	-	-	-
EBITDA margin	-1.36%	3.38%	-	-	-
NOPAT margin	-1.06%	1.68%	-	-	-
Sales SG rates	77.54%	74.69%	99.97%	99.97%	99.47%
Sales SG&A rates	22.79%	22.41%	0.02%	0.02%	-
Sales R&D expenses rates	3.09%	2.71%	-	-	-
Sales depreciation rates	0.41%	0.57%	-	-	-
Capital expenditures net sales ratio	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Growth
Growth rate of cash	-	-13.58%	-99.87%	-12.46%	-100.00%
Equity growth	-	3.25%	2.89%	2.33%	0.87%
Total assets growth	-	-1.12%	5.47%	0.16%	1.49%
Sales growth	-	-4.65%	5.45%	2.83%	-0.17%
Net profit growth	-	224.73%	57.04%	-29.46%	-65.13%
Operating C/F growth	-	-	-	-	-
Recurring profit growth	-	4,691.74%	46.73%	-33.45%	7.95%
EBIT growth	-	250.22%	-99.87%	-18.45%	-100.00%
EBITDA growth	-	336.56%	-99.88%	-16.96%	-100.00%
NOPAT growth	-	250.22%	-99.87%	-18.45%	-100.00%
Operating expenses growth	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Stability
Capital adequacy	47.92%	50.04%	48.82%	49.88%	49.57%
Liquidity ratio	158.78%	161.06%	160.70%	156.70%	-
C/F ratio current liabilities	-	-	-	-	-
Quick ratio	121.77%	123.49%	120.69%	114.88%	-
Fixed ratio	33.87%	29.83%	0.02%	0.02%	-
D/E ratio	7.71%	6.35%	-	-	-
Loan to Value Ratio	3.69%	3.17%	-	-	-
Business investment C/F ratio	-	-	-	-	-
Liabilities with interest growth	-	-15.00%	-99.90%	-	-100.00%
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Turnover
Cash turnover	52.06day	47.18day	0.05day	0.04day	-
Receivables turnover	99.56day	112.32day	0.11day	0.10day	-
Inventory turnover	32.71day	33.54day	0.03day	0.03day	-
Fixed assets turnover	48.77day	46.50day	0.04day	0.03day	-
Total asset turnover	300.37day	311.49day	311.55day	303.47day	308.54day
Payable turnover	95.40day	102.94day	0.11day	0.11day	-
Capital turnover	56.46day	59.21day	0.05day	0.05day	-
Equity turnover	143.96day	155.89day	152.11day	151.37day	152.97day
Working capita turnover	36.87day	42.91day	0.02day	0.02day	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Balance sheet
Cash etc.	¥ 2 B	¥ 2 B	¥ 3 M	¥ 2 M	-
Accounts receivable-trade	¥ 5 B	¥ 5 B	¥ 6 M	-	-
Other Current Assets	¥ 7 B	¥ 8 B	¥ 9 M	¥ 9 M	-
Current Assets	¥ 10 B	¥ 10 B	¥ 12 M	-	-
Tangible Assets	¥ 2 B	¥ 2 B	¥ 2 M	¥ 2 M	-
Intangible Assets	¥ 228 M	¥ 216 M	¥ 183 K	¥ 143 K	-
Investment etc.	¥ 2 B	¥ 2 B	¥ 16 B	¥ 16 B	¥ 17 B
Total Assets	¥ 16 B	¥ 16 B	¥ 16 B	¥ 16 B	¥ 17 B
Current Liabilities	¥ 6 B	¥ 6 B	¥ 7 M	¥ 7 M	¥ 8 B
Fixed Liabilities	¥ 1 B	¥ 1 B	¥ 1 M	¥ 866 K	-
Liabilities with interest	¥ 600 M	¥ 510 M	¥ 510 K	¥ 510 K	-
Net Assets	¥ 7 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
Capital stock	¥ 3 B	¥ 3 B	¥ 3 M	¥ 3 M	-
Capital surplus etc.	¥ 4 B	¥ 4 B	¥ 8 B	¥ 8 B	¥ 8 B
Liabilities and net assets	¥ 16 B	¥ 16 B	¥ 16 M	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Income statement
Sales	¥ 19 B	¥ 18 B	¥ 19 B	¥ 20 B	¥ 20 B
Cost of Sales	¥ 15 B	¥ 14 B	¥ 19 B	¥ 20 B	¥ 20 B
Gross profit	¥ 4 B	¥ 4 B	¥ 5 M	¥ 4 M	¥ 106 M
Other income	¥ 290 M	¥ 119 M	¥ 206 K	¥ 201 K	-
SG&A	¥ 4 B	¥ 4 B	¥ 4 M	¥ 4 M	-
Other expenses	¥ 444 M	¥ 389 M	¥ 490 K	¥ 350 K	-
Net income	¥ -220 M	¥ 274 M	¥ 431 M	¥ 304 M	¥ 106 M
Operating income	¥ -66 M	¥ 544 M	¥ 715 M	¥ 452 M	¥ 502 M
Ordinary Income	¥ -12 M	¥ 566 M	¥ 831 M	¥ 553 M	¥ 597 M
EBITDA	¥ -269 M	¥ 636 M	¥ 755 K	¥ 627 K	-
Income before income taxes	¥ -330 M	¥ 545 M	¥ 669 K	-	-
Depreciation	¥ 82 M	¥ 108 M	¥ 103 K	¥ 95 K	-
R&D expenses	¥ 609 M	¥ 511 M	¥ 595 K	-	-
Income taxes	¥ -110 M	¥ 270 M	¥ 238 K	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Cash flow statement
Operating CF	-	-	-	-	-
Investment CF	-	-	-	-	-
Financial CF	-	-	-	-	-
Foreign Exchange Effects	-	-	-	-	-
Net Change in Cash	-	-	-	-	-
Free CF	-	-	-	-	-
Capital expenditures	-	-	-	-	-
Cash dividends paid	-	-	-	-	-
Repayment loans	-	-	-	-	-
Indicator	2009-03-31	2010-03-31	2011-03-31	2012-03-31	2013-03-31
Shareowners' equity
Issuance of new shares	-	-	-	-	-
Dividends from surplus	¥ -178 M	¥ -74 M	¥ -103 K	-	-
Net income	¥ -220 M	¥ 274 M	¥ 431 K	-	-
Purchase of treasury stock	¥ -5 M	¥ -376 K	¥ -77 K	-	-
Other Change in Stockholders Equity	-	¥ -1 K	¥ -2	-	-
Other Change in Net Assets	¥ -122 M	¥ 53 M	¥ -18 K	-	-
Net Change in Net Assets	¥ -526 M	¥ 252 M	¥ 233 K	-	-

Free Download

*Free Download Financial Indicator dataMember limited service.

[Data] Net Profit Margin, Sales Growth, Equity Margin etc., 100 or more kinds of financial indicators. (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: CEMEDINE (Annual )

Statement Type

Annual : CEMEDINE

First quarter : CEMEDINE

Second quarter : CEMEDINE

Third quarter : CEMEDINE

Analysis Menu

Outline : CEMEDINE

Statement : CEMEDINE

Rating : CEMEDINE

Indicator : CEMEDINE

Download : CEMEDINE

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Tokyo - EDIUNET Prefectures

Tokyo品川区 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
CEMEDINE	4999	TSE 2st	Chemicals	3	Annual	BB

Related Company

TAKAGI SEIKO (Sales ¥ 53 B)

Toho Acetylene (Sales ¥ 35 B)

ATOMIX (Sales ¥ 10 B)

FANCL (Sales ¥ 82 B)

SHINTO PAINT (Sales ¥ 23 B)

TAIYO NIPPON SANSO (Sales ¥ 468 B)

旭化学工業 (Sales ¥ 6 B)

Tokuyama (Sales ¥ 258 B)

Maruo Calcium (Sales ¥ 9 B)

katakura chikkarin (Sales ¥ 20 B)

ASAHIPEN (Sales ¥ 14 B)

NIPPON CARBIDE INDUSTRIES (Sales ¥ 50 B)

TEIJIN　 (Sales ¥ 745 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .